Labisia pumila Prevents Complications of Osteoporosis by Increasing Bone Strength in a Rat Model of Postmenopausal Osteoporosis
- PMID: 22991574
- PMCID: PMC3443997
- DOI: 10.1155/2012/948080
Labisia pumila Prevents Complications of Osteoporosis by Increasing Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Abstract
Estrogen replacement therapy (ERT) is the main treatment postmenopausal osteoporosis. However, ERT causes serious side effects, such as cancers and thromboembolic problems. Labisia pumila var. alata (LPva) is a herb with potential as an alternative to ERT to prevent complications of osteoporosis, especially fragility fractures. This study was conducted to determine the effects of LPva on the biomechanical strength of femora exposed to osteoporosis due to estrogen deficiency, using the postmenopausal rat model. Thirty-two female rats were randomly divided into four groups: Sham-operated (Sham), ovariectomized control (OVXC), ovariectomized with Labisia pumila var. alata (LP), and ovariectomized with ERT (Premarin) (ERT). The LPva and ERT were administered via oral gavage daily at doses of 17.5 mg/kg and 64.5 μg/kg, respectively. Following two months of treatment, the rats were euthanized, and their right femora were prepared for bone biomechanical testing. The results showed that ovariectomy compromised the femoral strength, while LPva supplementation to the ovariectomized rats improved the femoral strength. Therefore, LPva may be as effective as ERT in preventing fractures due to estrogen-deficient osteoporosis.
Figures




Similar articles
-
Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model.BMC Complement Altern Med. 2013 Sep 5;13:217. doi: 10.1186/1472-6882-13-217. BMC Complement Altern Med. 2013. PMID: 24007208 Free PMC article.
-
Labisia pumila protects the bone of estrogen-deficient rat model: a histomorphometric study.J Ethnopharmacol. 2012 Jun 26;142(1):294-9. doi: 10.1016/j.jep.2012.04.029. Epub 2012 Apr 21. J Ethnopharmacol. 2012. PMID: 22542643
-
Time and dose-dependent effects of Labisia pumila on the bone strength of postmenopausal osteoporosis rat model.BMC Complement Altern Med. 2015 Mar 12;15:58. doi: 10.1186/s12906-015-0567-x. BMC Complement Altern Med. 2015. PMID: 25887391 Free PMC article.
-
Estrogen replacement therapy in the elderly.Zentralbl Gynakol. 1996;118(5):255-61. Zentralbl Gynakol. 1996. PMID: 8701621 Review.
-
Osteoporosis prevention and treatment with sex hormone replacement therapy.Clin Rheumatol. 1995 Sep;14 Suppl 3:14-7. doi: 10.1007/BF02210682. Clin Rheumatol. 1995. PMID: 8846655 Review.
Cited by
-
Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.Int J Clin Exp Med. 2015 Sep 15;8(9):16352-7. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26629156 Free PMC article.
-
Efficacy of Labisia pumila and Eurycoma longifolia standardised extracts on hot flushes, quality of life, hormone and lipid profile of peri-menopausal and menopausal women: a randomised, placebo-controlled study.Food Nutr Res. 2020 Sep 3;64. doi: 10.29219/fnr.v64.3665. eCollection 2020. Food Nutr Res. 2020. PMID: 33061884 Free PMC article.
-
Influence of cultural practices on breast cancer risks, stage at presentation and outcome in a multi-ethnic developing country.Oncol Lett. 2021 Nov;22(5):806. doi: 10.3892/ol.2021.13067. Epub 2021 Sep 23. Oncol Lett. 2021. PMID: 34630713 Free PMC article. Review.
-
Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model.BMC Complement Altern Med. 2013 Sep 5;13:217. doi: 10.1186/1472-6882-13-217. BMC Complement Altern Med. 2013. PMID: 24007208 Free PMC article.
-
In vitro study on efficacy of SKF7®, a Malaysian medicinal plant product against SARS-CoV-2.BMC Complement Med Ther. 2024 Sep 11;24(1):333. doi: 10.1186/s12906-024-04628-6. BMC Complement Med Ther. 2024. PMID: 39261916 Free PMC article.
References
-
- Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. The American Journal of Medicine. 1993;94:646–650. - PubMed
-
- World Health Organization. Summary Meeting Report. Brussels, Belgium: WHO Press; May 2004. WHO scientific group on the assessment of osteoporosis at primary health care level.
-
- Thomsen K, Gotfredsen A, Christiansen C. Is postmenopausal bone loss an age-related phenomenon? Calcified Tissue International. 1986;39(3):123–127. - PubMed
-
- Ismal NM. Postmenopausal osteoporosis: epidemiology, pathophysiology and treatment. The Malaysian Journal of Pathology. 1997;19(1):21–25. - PubMed
-
- International Osteoporosis Foundation. Facts and statistics about osteoporosis and its impact. International osteoporosis foundation. Journal of Bone and Mineral Research. 2009;4:113–118.
LinkOut - more resources
Full Text Sources